These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6127315)

  • 41. Antigenic relationships among type-1 fimbriae of Enterobacteriaceae revealed by immuno-electronmicroscopy.
    Adegbola RA; Old DC
    J Med Microbiol; 1987 Aug; 24(1):21-8. PubMed ID: 2886668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
    Ashworth LA; Robinson A; Irons LI; Morgan CP; Isaacs D
    Lancet; 1983 Oct; 2(8355):878-81. PubMed ID: 6137697
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does whole-cell pertussis vaccine protect black South African infants? Assessment of post-vaccination events and antibody responses to pertussis toxin, filamentous haemagglutinin and agglutinogens 2 and 3.
    Ramkissoon A; Coovadia HM; Loening WE; Ndlovana M
    S Afr Med J; 1991 Jun; 79(11):645-9. PubMed ID: 1675492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.
    Sato Y; Izumiya K; Sato H; Cowell JL; Manclark CR
    Infect Immun; 1981 Mar; 31(3):1223-31. PubMed ID: 6262248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eighty-kilodalton N-terminal moiety of Bordetella pertussis filamentous hemagglutinin: adherence, immunogenicity, and protective role.
    Alonso S; Reveneau N; Pethe K; Locht C
    Infect Immun; 2002 Aug; 70(8):4142-7. PubMed ID: 12117922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three-dimensional structure of Bordetella pertussis fimbriae.
    Heck DV; Trus BL; Steven AC
    J Struct Biol; 1996; 116(2):264-9. PubMed ID: 8812982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.
    Isacson J; Trollfors B; Hedvall G; Taranger J; Zackrisson G
    Scand J Infect Dis; 1995; 27(3):273-7. PubMed ID: 8539553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity of a five-component acellular pertussis vaccine in infants and young children.
    Halperin SA; Barreto L; Friesen B; Meekison W
    Arch Pediatr Adolesc Med; 1994 May; 148(5):495-502. PubMed ID: 7910089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. International collaborative study: evaluation of proposed International Reference Reagent of pertussis antiserum (mouse) 97/642.
    Gaines Das R; Xing D; Rigsby P; Newland P; Corbel M
    Biologicals; 2001 Jun; 29(2):137-48. PubMed ID: 11580218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.
    Storsaeter J; Hallander HO; Gustafsson L; Olin P
    Vaccine; 1998 Dec; 16(20):1907-16. PubMed ID: 9796042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
    Sato H; Sato Y
    Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
    Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
    Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cloning and immunologic characterization of a truncated Bordetella bronchiseptica filamentous hemagglutinin fusion protein.
    Keil DJ; Burns EH; Kisker WR; Bemis D; Fenwick B
    Vaccine; 1999 Dec; 18(9-10):860-7. PubMed ID: 10580199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year-old children. Elmwood Pediatric Associates, Pennridge Pediatric Associates.
    Annunziato PW; Rothstein EP; Bernstein HH; Blatter MM; Reisinger KS; Pichichero ME
    Arch Pediatr Adolesc Med; 1994 May; 148(5):503-7. PubMed ID: 8180641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of Bordetella pertussis with host immune cells in the mouse lung.
    Vandebriel RJ; Hellwig SM; Vermeulen JP; Hoekman JH; Dormans JA; Roholl PJ; Mooi FR
    Microb Pathog; 2003 Jul; 35(1):19-29. PubMed ID: 12860455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of immunodominant epitopes in the filamentous hemagglutinin of Bordetella pertussis.
    Piatti G
    FEMS Immunol Med Microbiol; 1999 Mar; 23(3):235-41. PubMed ID: 10219596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serospecific protection of mice against intranasal infection with Bordetella pertussis.
    Robinson A; Gorringe AR; Funnell SG; Fernandez M
    Vaccine; 1989 Aug; 7(4):321-4. PubMed ID: 2573215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of Bordetella pertussis components on IgE and IgG1 responses.
    Sekiya K
    Microbiol Immunol; 1983; 27(11):905-15. PubMed ID: 6321910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years.
    Cattaneo LA; Reed GW; Haase DH; Wills MJ; Edwards KM
    J Infect Dis; 1996 May; 173(5):1256-9. PubMed ID: 8627081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Filamentous hemagglutinin of Bordetella pertussis. A bacterial adhesin formed as a 50-nm monomeric rigid rod based on a 19-residue repeat motif rich in beta strands and turns.
    Makhov AM; Hannah JH; Brennan MJ; Trus BL; Kocsis E; Conway JF; Wingfield PT; Simon MN; Steven AC
    J Mol Biol; 1994 Aug; 241(1):110-24. PubMed ID: 7519681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.